Featured

Again, epilepsy drug from Delhi hospitals failed test

Days after Delhi Lt Governor V K Saxena recommended CBI enquiry into the procurement and supply of ‘spurious and non-standard drugs’ that were supplied to the Delhi Government hospitals, Raj Niwas officials on Wednesday said another medicine used for treating seizures and epilepsy have also failed the test. According to officials, another drug samples taken from Delhi government hospitals failed by the Regional Drug Testing Laboratory in Chandigarh.

Mr Saxena last week had recommended a CBI inquiry into the alleged supply of drugs that “failed quality standard tests” and have the “potential of endangering lives.”  After some complaints received from patients, samples were collected from three major Delhi govt Hospitals – IHBAS, Lok Nayak and Deen Dayal Upadhyay and were sent to the approved labs for testing. Over 10 per cent of the medicine samples failed and were found to be “Not of standard quality”. 

These drugs were procured by the Central Procurement Agency, under the Health Department of the city govt and supplied to various government hospitals.  The spurious and non-standard drugs being supplied include critical life-saving anti-biotic used for treatment of lungs and UT infections – Cephalexin, steroid for curing life threatening inflammation in lungs, joints and swelling in the body – Dexamethasone, Anti epilepsy and anti-anxiety psychiatric drug- Levetiracetam and anti-hypertension drug- Amlodepin.

“Series of medicines and drugs are not meeting the standards. Few days after LG referred the matter of fake drugs in Delhi govt hospitals and Mohalla clinics to CBI, one more Drug sample was failed by Regional Drug Testing Laboratory, (RDTL Chandigarh). This Time Anti epilepsy drug called “ Sodium Valporoate” was found to be not meeting the standards”, said an official from Raj Niwas.

The official said that this drug being supplied in Delhi Govt Hospitals was found to be of “Not of Standard Quality”.  The report was issued by Government Analyst ie RDTL on 22nd December 2023.

Medlarge

Recent Posts

ICMR starts first in-human clinical trials for Zika vaccine

The Indian Council of Medical Research (ICMR) has inked agreements with multiple stakeholders for the…

2 months ago

Akums Drugs gest patent for oral suspension of Hydroxyurea for Sickle Cell Disease

Pharma major Akums Drugs and Pharmaceuticals has secured a patent for its Room Temperature Stable…

2 months ago

NITI Ayog suggests separate legislation, fund for future pandemic

A report by an expert group set up by NITI Aayog report titled ‘Future Pandemic…

2 months ago

Health ministry seeks action-taken report from hospitals on Kolkata incident

The union health ministry has sought an action taken report from State governments and Union…

2 months ago

Jupiter hospital drives future of Healthcare Management with JASPER 2024

Jupiter Hospital, a leading tertiary care provider in Pune, recently hosted the Jupiter Administration Symposium…

2 months ago

Mock drill held on pandemic preparedness under National One Health Mission

Under the aegis of National One Health Mission (NOHM), a comprehensive national mock drill, "Vishanu…

2 months ago